Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
83 hedge funds and large institutions have $208M invested in Immunomedics Inc in 2013 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 28 increasing their positions, 28 reducing their positions, and 7 closing their positions.
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
52% more call options, than puts
Call options by funds: $15M | Put options by funds: $9.83M
29% more capital invested
Capital invested by funds: $162M → $208M (+$46.8M)
5% more funds holding
Funds holding: 79 → 83 (+4)
0% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
+$10.4M |
| 2 |
SCM
Sigma Capital Management
Stamford,
Connecticut
|
+$7.92M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.76M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.19M |
| 5 |
Renaissance Technologies
New York
|
+$1.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.37M |
| 2 |
B
Bailard
Foster City,
California
|
-$1.33M |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$1.22M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.07M |
| 5 |
Charles Schwab
San Francisco,
California
|
-$593K |
IMMU Hedge Fund Activity: Q3 2013 in Review
83 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q3 2013, worth a combined $208M — up 29% from $162M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new IMMU positions and 7 closed out — a net gain of 5 holders — while 28 added to existing stakes and 28 trimmed.
The largest buyer was SAC Capital Advisors, opening a new position worth an estimated $10.4M. The largest seller was Oxford Asset Management, exiting entirely with an estimated $1.37M sold.
- 83 institutional investors held Immunomedics Inc (IMMU) as of Q3 2013, up from 79 in Q2 2013.
- Funds reported $208M of Immunomedics Inc stock for Q3 2013, up 29% quarter-over-quarter.
- 12 funds opened new Immunomedics Inc positions in Q3 2013 and 7 closed out, a net change of +5 holders.
- The largest Immunomedics Inc buyer in Q3 2013 was SAC Capital Advisors, an estimated $10.4M added.
- The largest Immunomedics Inc seller in Q3 2013 was Oxford Asset Management, an estimated $1.37M sold.
Based on aggregated 13F filings for Q3 2013.